rdf:type |
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0003593,
umls-concept:C0003842,
umls-concept:C0005839,
umls-concept:C0023981,
umls-concept:C0042401,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0456603,
umls-concept:C0683598,
umls-concept:C1261322,
umls-concept:C1456594,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C2603343
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-1-16
|
pubmed:abstractText |
Recent studies have shown the apolipoprotein B to apolipoprotein A1 ratio (apoB/A1) to be superior to LDL-cholesterol measurements to predict cardiovascular events. The present study aims to relate apoB/A1 to endothelium-dependent vasodilation, an early marker of atherosclerosis, in the Prospective Study of the Vasculature in Uppsala Seniors (PIVUS) study.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-9150
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
190
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
378-84
|
pubmed:meshHeading |
pubmed-meshheading:16545386-Aged,
pubmed-meshheading:16545386-Apolipoprotein A-I,
pubmed-meshheading:16545386-Apolipoproteins B,
pubmed-meshheading:16545386-Blood Flow Velocity,
pubmed-meshheading:16545386-Blood Pressure,
pubmed-meshheading:16545386-Body Mass Index,
pubmed-meshheading:16545386-Cardiovascular Diseases,
pubmed-meshheading:16545386-Female,
pubmed-meshheading:16545386-Humans,
pubmed-meshheading:16545386-Lipoproteins,
pubmed-meshheading:16545386-Male,
pubmed-meshheading:16545386-Medical History Taking,
pubmed-meshheading:16545386-Normal Distribution,
pubmed-meshheading:16545386-Sweden,
pubmed-meshheading:16545386-Vascular Resistance,
pubmed-meshheading:16545386-Vasodilation
|
pubmed:year |
2007
|
pubmed:articleTitle |
Vasodilation in resistance arteries is related to the apolipoprotein B/A1 ratio in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
|
pubmed:affiliation |
Department of Medicine, Uppsala University Hospital, AstraZeneca R&D Mölndal, 751 85 Uppsala, Sweden. lars.lind@medsci.uu.se
|
pubmed:publicationType |
Journal Article
|